Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Frequent antibiotic use and second breast cancer events.

Wirtz HS, Buist DS, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJ, Fujii M, Boudreau DM.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1588-99. doi: 10.1158/1055-9965.EPI-13-0454. Epub 2013 Jul 5.

2.

Associations between diabetes medication use and risk of second breast cancer events and mortality.

Calip GS, Yu O, Hoskins KF, Boudreau DM.

Cancer Causes Control. 2015 Aug;26(8):1065-77. doi: 10.1007/s10552-015-0599-z. Epub 2015 May 9.

3.

Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.

Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS.

Breast Cancer Res Treat. 2014 Apr;144(2):405-16. doi: 10.1007/s10549-014-2870-5. Epub 2014 Feb 21.

4.

Metabolic syndrome and outcomes following early-stage breast cancer.

Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM.

Breast Cancer Res Treat. 2014 Nov;148(2):363-77. doi: 10.1007/s10549-014-3157-6. Epub 2014 Oct 10.

5.

Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.

Kwan ML, Chen WY, Flatt SW, Weltzien EK, Nechuta SJ, Poole EM, Holmes MD, Patterson RE, Shu XO, Pierce JP, Caan BJ.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):32-41. doi: 10.1158/1055-9965.EPI-12-1022. Epub 2012 Nov 13.

6.

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.

Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P.

JAMA Oncol. 2015 Oct;1(7):888-96. doi: 10.1001/jamaoncol.2015.2510.

PMID:
26291673
7.

Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis.

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI.

Cancer Res. 2017 Nov 1;77(21):6033-6041. doi: 10.1158/0008-5472.CAN-17-0687. Epub 2017 Sep 21.

PMID:
28935814
8.

Statin use and breast cancer risk in a large population-based setting.

Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):416-21.

9.

Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.

Wirtz HS, Calip GS, Buist DSM, Gralow JR, Barlow WE, Gray S, Boudreau DM.

Am J Epidemiol. 2017 Apr 15;185(8):661-672. doi: 10.1093/aje/kww242.

PMID:
28338879
10.

Breast cancer recurrence in relation to antidepressant use.

Chubak J, Bowles EJ, Yu O, Buist DS, Fujii M, Boudreau DM.

Cancer Causes Control. 2016 Jan;27(1):125-36. doi: 10.1007/s10552-015-0689-y. Epub 2015 Oct 30.

11.

Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study.

Kwan ML, Greenlee H, Lee VS, Castillo A, Gunderson EP, Habel LA, Kushi LH, Sweeney C, Tam EK, Caan BJ.

Breast Cancer Res Treat. 2011 Nov;130(1):195-205. doi: 10.1007/s10549-011-1557-4. Epub 2011 May 11.

12.

Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.

Kroenke CH, Chubak J, Johnson L, Castillo A, Weltzien E, Caan BJ.

J Natl Cancer Inst. 2015 Nov 18;108(3). pii: djv336. doi: 10.1093/jnci/djv336. Print 2016 Mar. Erratum in: J Natl Cancer Inst. 2016 Mar;108(3). pii: djw025. doi: 10.1093/jnci/djw025. J Natl Cancer Inst. 2016 Mar;108(3). pii: djw017. doi: 10.1093/jnci/djw017.

PMID:
26582243
13.

Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort.

Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, Ambs A, Ballard-Barbash R, Neuhouser ML.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):890-9. doi: 10.1158/1055-9965.EPI-10-1278. Epub 2011 Mar 23.

14.

Antibiotic use in relation to the risk of breast cancer.

Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH.

JAMA. 2004 Feb 18;291(7):827-35.

PMID:
14970061
15.

Mammography use, breast cancer stage at diagnosis, and survival among older women.

McCarthy EP, Burns RB, Freund KM, Ash AS, Shwartz M, Marwill SL, Moskowitz MA.

J Am Geriatr Soc. 2000 Oct;48(10):1226-33.

PMID:
11037009
16.

Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1603-1610. doi: 10.1158/1055-9965.EPI-17-0346. Epub 2017 Aug 14.

PMID:
28807926
17.

Racial disparities in breast cancer survival: an analysis by age and stage.

Deshpande AD, Jeffe DB, Gnerlich J, Iqbal AZ, Thummalakunta A, Margenthaler JA.

J Surg Res. 2009 May 1;153(1):105-13. doi: 10.1016/j.jss.2008.05.020. Epub 2008 Jun 23.

18.

Survival differences among women with de novo stage IV and relapsed breast cancer.

Dawood S, Broglio K, Ensor J, Hortobagyi GN, Giordano SH.

Ann Oncol. 2010 Nov;21(11):2169-74. doi: 10.1093/annonc/mdq220. Epub 2010 Apr 28.

19.

Hazard of recurrence among women after primary breast cancer treatment--a 10-year follow-up using data from SEER-Medicare.

Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, Buchholz TA, Giordano SH.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):800-9. doi: 10.1158/1055-9965.EPI-11-1089. Epub 2012 Mar 16. Erratum in: Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1604-5.

20.

Risk of cardiac death after adjuvant radiotherapy for breast cancer.

Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS.

J Natl Cancer Inst. 2005 Mar 16;97(6):419-24.

Supplemental Content

Support Center